VRS
NBIX icon

Virginia Retirement Systems’s Neurocrine Biosciences NBIX Stock Holding History

Virginia Retirement Systems’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$20.9M Buy
147,623
+49,200
+50% +$7.13M 0.12% 177
2025
Q3 		$13.8M Buy
98,423
+13,300
+16% +$1.8M 0.09% 213
2025
Q2 		$10.7M Sell
85,123
-334,500
-80% -$38.4M 0.07% 224
2025
Q1 		$46.4M Buy
+419,623
New +$53.2M 0.34% 81
2023
Q3 		$67.6M Buy
600,823
+456,800
+317% +$48.1M 0.67% 31
2023
Q2 		$13.6M Sell
144,023
-36,300
-20% -$3.55M 0.13% 177
2023
Q1 		$18.3M Buy
180,323
+3,523
+2% +$367K 0.19% 151
2022
Q4 		$21.1M Sell
176,800
-6,200
-3% -$726K 0.22% 118
2022
Q3 		$19.4M Buy
+183,000
New +$18.6M 0.22% 121
2021
Q2 		– Sell
-2,700
Closed -$263K – 1104
2021
Q1 		$263K Buy
+2,700
New +$283K ﹤0.01% 1023
2020
Q3 		– Sell
-14,700
Closed -$1.79M – 1144
2020
Q2 		$1.79M Buy
14,700
+8,900
+153% +$984K 0.02% 402
2020
Q1 		$502K Sell
5,800
-20,100
-78% -$1.97M 0.01% 793
2019
Q4 		$2.78M Buy
25,900
+8,900
+52% +$932K 0.03% 382
2019
Q3 		$1.53M Buy
17,000
+200
+1% +$18.7K 0.02% 517
2019
Q2 		$1.42M Buy
16,800
+7,900
+89% +$649K 0.02% 547
2019
Q1 		$784K Buy
8,900
+2,700
+44% +$226K 0.01% 752
2018
Q4 		$443K Hold
6,200
– – 0.01% 908
2018
Q3 		$762K Hold
6,200
– – 0.01% 795
2018
Q2 		$609K Buy
+6,200
New +$555K 0.01% 845

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Virginia Retirement Systems's NBIX Position: Q4 2025 in Review

Virginia Retirement Systems increased its Neurocrine Biosciences (NBIX) stake by 50% in Q4 2025, buying an estimated $7.13M and bringing the position to 147,623 shares worth $20.9M. The position accounts for 0.12% of the portfolio, ranked #177.

Virginia Retirement Systems first reported a position in NBIX in Q2 2018 and has held it in 19 quarters since. The position peaked at $67.6M in Q3 2023. 730 funds tracked by Wall St. Rank hold NBIX as of Q4 2025.

  • Virginia Retirement Systems held 147,623 shares of Neurocrine Biosciences worth $20.9M as of Q4 2025.
  • Virginia Retirement Systems bought 49,200 Neurocrine Biosciences shares in Q4 2025, an estimated $7.13M.
  • Neurocrine Biosciences made up 0.12% of Virginia Retirement Systems's portfolio in Q4 2025, its #177 holding.
  • Virginia Retirement Systems first reported a position in Neurocrine Biosciences in Q2 2018 and has held it in 19 quarters since.
  • Virginia Retirement Systems's Neurocrine Biosciences position peaked at $67.6M in Q3 2023.
  • 730 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.